Arjun Goyal, a director at Centessa Pharmaceuticals plc ($CNTA), made two open market purchases of common shares worth nearly $5.9 million over the last 365 days, with his most recent buy on May 16, 2025. His total ranks 150th among nearly 5,000 individual insiders, beating the average purchase amount of $1.5 million across 3.3 transactions. Goyal reported no open market sales in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 20, 2025 | Centessa Pharmaceuticals plc | $CNTA | GOYAL ARJUN | Director | A | Share Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 133,184,349 | 9999.99% | 0.03% |
| May 15, 2025 | Centessa Pharmaceuticals plc | $CNTA | GOYAL ARJUN | Director | P | Ordinary Shares | 44939 | $12.24 | 44,939.0000 | 133,184,349 | 9999.99% | 0.03% |
| May 16, 2025 | Centessa Pharmaceuticals plc | $CNTA | GOYAL ARJUN | Director | P | Ordinary Shares | 417646 | $12.73 | 462,585.0000 | 133,184,349 | 929.36% | 0.31% |
| June 25, 2024 | Centessa Pharmaceuticals plc | $CNTA | GOYAL ARJUN | Director | A | Share Option (right to buy) | 48000 | $0.00 | 48,000.0000 | 0 | 9999.99% | 0.00% |
| June 22, 2023 | Centessa Pharmaceuticals plc | $CNTA | GOYAL ARJUN | Director | A | Share Option (right to buy) | 48000 | $0.00 | 48,000.0000 | 0 | 9999.99% | 0.00% |